Sentinel lymph node mapping versus systematic lymphadenectomy in obese women undergoing minimally invasive surgery for endometrial cancer: A propensity-matched analysis

Sentinel SENECA risk factors for unsuccessful bi-lateral sentinel lymph node mapping in endometrial cancer

10.1016/j.ijgc.2025.101771 · doi-reference

Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping

10.1136/ijgc-2020-001724 · doi-reference

The impact of obesity on sentinel lymph node mapping in endometrial cancer: not a one-size-fits-all-model

10.1016/j.ijgc.2026.104784 · doi-reference

Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis

10.1016/j.ajog.2016.11.1033 · doi-reference

Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: a systematic review and meta-analysis

10.1136/ijgc-2022-004014 · doi-reference

The PROMISE-EC study: prognostic role of molecular classification and sentinel lymph node status in early-stage endometrial cancer

10.1016/j.ijgc.2026.104796 · doi-reference

Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups

10.1016/j.ygyno.2024.12.014 · doi-reference

Analysis of sentinel lymph node adoption compared to systematic lymphadenectomy in staging early endometrial cancer at a tertiary center: an ambispective study

10.1002/jso.70008 · doi-reference

The impact of body mass index on sentinel lymph node identification in endometrial cancer

10.21873/anticanres.17538 · doi-reference

Predictors for sentinel lymph node mapping failure using indocyanine green injection in apparent early stages of endometrial cancer: a single-center prospective study

10.1002/ijgo.70123 · doi-reference

Adherence to ESGO guidelines and impact on survival in obese patients with endometrial cancer: a multicentric retrospective study

10.1136/ijgc-2023-004642 · doi-reference

Successful bilateral sentinel lymph node mapping rate and empty nodal packet rate in uterine cancer

10.1016/j.ijgc.2026.104674 · doi-reference

Impact of obesity on sentinel lymph node mapping in patients with apparent early-stage endometrial cancer: the ObeLyX study

10.1016/j.ygyno.2022.03.003 · doi-reference

Impact of obesity in the identification of the sentinel lymph node in endometrial cancer: a retrospective, monocentric study and literature review

10.1007/s00404-024-07386-5 · doi-reference

Morbid obesity increases the failure rate of sentinel lymph node mapping for endometrial carcinoma

10.1007/s11701-023-01609-8 · doi-reference

Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics

10.1016/j.ajog.2021.05.034 · doi-reference

Assessment of sentinel lymph node biopsy vs lymphadenectomy for Intermediate- and high-grade endometrial cancer staging

10.1001/jamasurg.2020.5060 · doi-reference

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study

10.1016/s1470-2045(17)30068-2 · doi-reference

Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

10.1067/mob.2000.107335 · doi-reference

Endometrial cancer

10.1016/s0140-6736(22)00323-3 · doi-reference

ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025

10.1016/s1470-2045(25)00167-6 · doi-reference

Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies

10.1093/annonc/mdv142 · doi-reference